RET RNA Rearrangement

Understand what RET RNA Rearrangement signals

LOINC codes: 30896-5, 51968-6
Commercial laboratory assays: 1

We have not added a physiological summary for this biomarker yet. Compare the commercial laboratory assays and population reference ranges below.

Compare commercial laboratory assays for RET RNA Rearrangement

Check orderable catalog codes, specimen types, fasting requirements, and demographic reference ranges across laboratories.

FusionSEQ Panel

Laboratory: Quest Diagnostics
Test code: 12353
Specimen: 6-10 slides (10-micron sections) for resection or surgical specimens or 10-20 slides (10-micron sections) for core needle biopsies with H&E slide in slide holder
Fasting: Not stated
LOINC: 30896-5, 51968-6
Turnaround: Set up: Daily

Laboratory assay overview

The FusionSEQ assay detects the presence of known and novel gene rearrangements (fusions) and exon skipping events in clinically relevant genes associated with the pathogenesis of many pediatric and adult solid tumors malignancies. FDA approved therapies and clinical trials are available for patients with these genomic abnormalities in certain solid tumors, and the detection of these abnormalities is beneficial in the management of disease and survival of the patient.

View complete laboratory reference notes

See Laboratory Report

Quest Diagnostics test directory, test code 12353

Verify these ranges and sources

We compile every detail above directly from named laboratory directories and published clinical studies. Laboratories calculate standard reference intervals from the statistical distribution of tested populations for a specific assay method and demographic group, rather than setting universal optimal targets.

Always review your personal lab results with a licensed clinician, or track your lab history and health goals in Aumnivida.

Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.